참고문헌
- Suh JS. Diagnosis and Management of Chronic Kidney Disease-Mineral Bone Disease in Children. Childhood Kidney Diseases 2020;24:14-8. https://doi.org/10.3339/jkspn.2020.24.1.14
- Heaf JG. Chronic Kidney Disease-Mineral Bone Disorder in the Elderly Peritoneal Dialysis Patient. Perit Dial Int 2015;35:640-4. https://doi.org/10.3747/pdi.2014.00339
- Goel SK, Bellovich K, McCullough PA. Treatment of severe metastatic calcification and calciphylaxis in dialysis patients. Int J Nephrol 2011;2011:701603. https://doi.org/10.4061/2011/701603
- Drueke TB. A clinical approach to the uraemic patient with extraskeletal calcifications. Nephrology Dialysis Transplantation 1996;11:37-42. https://doi.org/10.1093/ndt/11.supp3.37
- Milliner DS, Zinsmeister AR, Lieberman E, Landing B. Soft tissue calcification in pediatric patients with end-stage renal disease. Kidney Int 1990;38:931-6. https://doi.org/10.1038/ki.1990.293
- Sheth RD, Perez MD, Goldstein SL. Cardiovascular calcifications in pediatric patients receiving maintenance dialysis. Pediatr Nephrol 2003;18:810-3. https://doi.org/10.1007/s00467-003-1156-7
- Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2017;7:1-59. https://doi.org/10.1016/j.kisu.2017.04.001
- Wesseling K, Bakkaloglu S, Salusky I. Chronic kidney disease mineral and bone disorder in children. Pediatr Nephrol 2008;23:195-207. https://doi.org/10.1007/s00467-007-0671-3
- Palit S, Kendrick J. Vascular calcification in chronic kidney disease: role of disordered mineral metabolism. Curr Pharm Des 2014;20:5829-33. https://doi.org/10.2174/1381612820666140212194926
- Kim C, Cheong HI, Kim JH, Yu YS, Kwon JW. Presumed atypical HDR syndrome associated with Band Keratopathy and pigmentary retinopathy. J Pediatr Ophthalmol Strabismus 2011;48 Online:e1-3.
- Khouzam N, Wesseling-Perry K. Pathophysiology and treatment of cardiovascular disease in pediatric chronic kidney disease. Pediatr Nephrol 2019;34:1-10. https://doi.org/10.1007/s00467-017-3798-x
- Fathallah-Shaykh S, Drozdz D, Flynn J, Jenkins R, Wesseling-Perry K, Swartz SJ, et al. Efficacy and safety of sevelamer carbonate in hyperphosphatemic pediatric patients with chronic kidney disease. Pediatr Nephrol 2018;33:325-33. https://doi.org/10.1007/s00467-017-3787-0
- Toussaint N, Cooney P, Kerr PG. Review of dialysate calcium concentration in hemodialysis. Hemodial Int 2006;10:326-37. https://doi.org/10.1111/j.1542-4758.2006.00125.x
- Warady BA, Iles JN, Ariceta G, Dehmel B, Hidalgo G, Jiang X, et al. A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet in pediatric patients with chronic kidney disease and secondary hyperparathy.